Dfas-jfll/in in Apo, AA - Clinic/Center

Dfas-jfll/in is a dental clinic (Clinic/center - Dental) in Apo, Armed Forces Americas. The current practice location for Dfas-jfll/in is 238 Brookley Avenue, Building 1300, Apo, Armed Forces Americas. For appointments, you can reach them via phone at (888) 999-1212. The mailing address for Dfas-jfll/in is 238 Brookley Ave Sw, Building 1300, Bolling Afb, District Of Columbia and phone number is (888) 999-1212.

Dfas-jfll/in is licensed to practice in Virginia (license number ) and its NPI number is 1639528441. This medical practice does not participate in medicare program and thus may not accept your medicare insurance. You may check if they accept your insurance at (888) 999-1212.

Contact Information

	Dfas-jfll/in
	238 Brookley Avenue Building 1300 Apo AA 20032-0101
	(888) 999-1212
	Not Available

Dental Care Clinic Profile

Full Name	Dfas-jfll/in
Speciality	Clinic/center - Dental
Location	238 Brookley Avenue, Apo, Armed Forces Americas
Authorized Official Name and Position	Yuehang Su (DENTIST)
Authorized Official Contact	3212764231
Accepts Medicare Insurance	This clinic does not participate in Medicare Program.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dfas-jfll/in 238 Brookley Ave Sw Building 1300 Bolling Afb DC 20032-7704 Ph: (888) 999-1212	Dfas-jfll/in 238 Brookley Avenue Building 1300 Apo AA 20032-0101 Ph: (888) 999-1212

NPI Details:

NPI Number	1639528441
Provider Enumeration Date	06/13/2016
Last Update Date	06/13/2016

Medical Identifiers

Medical identifiers for Dfas-jfll/in such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1639528441	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
261QD0000X	Clinic/center - Dental	(Virginia)	Primary

News Archive

European Phase III clinical trial of budesonide MMX completes patient enrollment

Santarus, Inc., a specialty biopharmaceutical company, today announced that its collaboration partner, Cosmo Technologies Ltd., a subsidiary of Cosmo Pharmaceuticals SpA (SIX: COPN), has completed enrollment of 514 patients in the European Phase III clinical trial to evaluate budesonide MMX® administered over eight weeks for the induction of remission of mild or moderate active ulcerative colitis.

Photodynamic therapy may be an effective treatment for infections of the oral cavity

Researchers found that the bacteria S. mutans, as well as fungal organisms of the genus Candida, cultured from HIV patients, were highly susceptible to killing with minimal doses of PDT, both in laboratory dishes and on biofilms grown on denture material.

1 in 6 public health workers would not report to work during a pandemic flu emergency

The findings are a significant improvement over a 2005 study conducted by the same research team, in which more than 40 percent of public health employees said they were unlikely to report to work during a pandemic emergency. The new study suggests ways for improving the response of the public health workforce. The results are published in the July 24 edition of the journal PLoS ONE.

Fat cells release a protein that aids insulin secretion from pancreatic beta cells

The body's fat cells help the pancreas do its job of secreting insulin, according to research at Washington University School of Medicine in St. Louis.

Smoking in women associated with skin cancer: Study

A new study has found a link between tobacco use and skin cancer especially in women. The study found that women who had squamous cell skin cancer were more likely to have smoked than those who were free from the disease. And those who smoked at least 20 years were twice as likely to develop squamous cell skin cancer - a less aggressive form of skin cancer as melanoma.

Dfas-jfll/in - Dental Clinic in Apo, AA